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Abstract 
Introduction: Aspartame (or APM) is the name for an artificial, non-saccharide sweetener used 
as a sugar substitute in many foods and beverages. Aspartame is the methyl ester of a 
phenylalanine/aspartic acid dipeptide. Aspartame is an artificial sweetener. It is 200 times 
sweeter than sugar in typical concentrations, without the high-energy value of sugar. Objective: 
To study the awareness of pharmacists about aspartame side effects. Materials and methods: 
This study was carried in greater Khartoum, questionnaire for pharmacists to see the 
consumption and the awareness of them to these interactions during the period from September 
2014 to November 2014.Study was conducted among practicing pharmacists. A pre designed and 
tested questionnaire were used for each category to collect the data. From the hospitals manager. 
Result: 32% were aware of the number of aspartame products. Pharmacists when asked how 
many patients purchase aspartame products per day, answers showed that 74.5% ranged between 
1-10 patients per day, About pharmacist’s expectations to develop side effects due to aspartame, 
use regularly showed that 75% agreed that it would. pharmacists claimed that aspartame can or 
worsen a certain list of some diseases in which that diabetes represented 30%, Alzheimer’s 28% , 
attention deficit disorder 17.3% , psychological disorders. Conclusion: The majority of 
community pharmacists expect side effects can be developed due to aspartame regular use by 
patients but majority didn’t know what are the exact side effects and the exact diseases that can 
be worsened when using aspartame. 
Introduction 
Aspartame (or APM) is the name for an artificial, non-saccharide sweetener used as a sugar 
substitute in many foods and beverages. Aspartame is the methyl ester of a 
phenylalanine/aspartic acid dipeptide.Aspartame was first synthesized in 1965. The United States 
Food and Drug Administration approved its use in food products in 1980. Because its breakdown 
products include phenylalanine, aspartame is among the many substances that must be avoided 
by people with phenylketonuria (PKU), a rare genetic condition.The safety of aspartame has 
been the subject of several political and medical controversies since its initial approval by the 
U.S. Food and Drug Administration (FDA) in 1974. 
Chemistry: 
Aspartame is the methyl ester of the dipeptide of the natural amino acids L-aspartic acid and L-
phenylalanine. Under strongly acidic or alkaline conditions, aspartame may generate methanol 
by hydrolysis. Under more severe conditions, the peptide bonds are also hydrolysed, resulting in 
the free amino acids. In certain markets, aspartame is manufactured using a genetically modified 
variation of E. coli. 
(1, 2)
 
General Notices (PhEur monograph 0973) 
(11)
 
  
 
Structural Formula 
 
General Formula and 
Molecular Weight 
C14H18N2O5 294.3  53906-69-7 
Action And Use Sweetening agent. 
Definition (3S)-3-Amino-4-[[(1S)-1-benzyl-2-methoxy-2-oxoethyl] amino]-4-
oxobutanoic acid. 
Content 98.0 per cent to 102.0 per cent (dried substance). 
Toxicity Fingernail polish (dry), Rust. 
Raw Materials L-Phenylalanine Methyl Ester HCI 
N-Benzyloxycarbonyl-L-aspartic acida-p-nitrophenyl, β benzyl 
Diester
(12)
 
Hydrogen 
Properties and use: 
Aspartame is an artificial sweetener. It is 200 times sweeter than sugar in typical concentrations, 
without the high-energy value of sugar. While aspartame, like other peptides, has a caloric value 
of 4 kilocalories (17 kilojoules) per gram, the quantity of aspartame needed to produce a sweet 
taste is so small that its caloric contribution is negligible. 
(3)
 
Discovery and approval: 
James M. Schlatter, a chemist working for G.D. Searle & Company, discovered aspartame in 
1965. Schlatter had synthesized aspartame in the course of producing an anti-ulcer drug 
candidate. He accidentally discovered its sweet taste when he licked his finger, which had 
become contaminated with aspartame. 
(4)
 
Metabolism and phenylketonuria: 
Upon ingestion, aspartame breaks down into natural residual components, including aspartic 
acid, phenylalanine, methanol 
(5)
, and further breakdown products including formaldehyde 
(6)
, 
known to have a number of detrimental effects on the human body 
(7)
, formic acid , and a DKP - 
Aspartylphenylalaninediketopiperazine
(8)
.Further studies have shown that a metabolite of 
aspartame inhibits angiotensin-converting enzyme.
(9)
 
Safety controversy: 
A study performed by Northeastern Ohio Universities College of Medicine found that 
individuals with mood disorders are particularly sensitive to this artificial sweetener, and its use 
in this population should be discouraged. 
(10)
 
Materials and methods 
This study was carried in greater Khartoum, questionnaire for pharmacists to see the 
consumption and the awareness of them to these interactions during the period from September 
2014 to November 2014. 
  
 
Study was conducted among practicing pharmacists. A pre designed and tested questionnaire 
were used for each category to collect the data needed.    
A pre designed and tested questionnaire were used for each category to collect the data. The data 
was collected, entered, cleaned and analyzed using SPSS software version 17. Permission to 
access the data in the patient records anonymously was obtained from the hospitals manager.   
Result 
Figure (1): Distribution of study sample according to gender. 
Figure (2): Distribution of study sample according to year of experience. 
Figure (3): Distribution of study sample according to qualification. 
Figure 4: Distribution of study sample according to do you know number of products 
containing aspartame in Sudan. 
  
 
Figure 5: Frequency of do you know number of products containing aspartame in Sudan 
if yes among study population. 
Figure (6): Distribution of study sample according to the number of patients for whom 
aspartame products are dispensed per day. 
Figure (7): Do you expect there will be side effects for aspartame when used regularly. 
Figure (8): Do you expect there will be side effects for aspartame itself. 
Figure (9): Do you expect there will be side effects for aspartame Metabolism 
  
 
Figure (10): Frequency of Side effect expected when using aspartame among study 
population 
Figure (11): Frequency of aspartame can mimic symptoms, worsen, or cause the 
following disease among study population. 
Discussion 
Aspartame has been and for a very long time an overlooked  entity an additive in the daily lives 
of patients, especially more that are seeking a change in life style towards certain health goals 
such as weight control, diabetes control, to ebb on excessive sugar and carbohydrate intake. In 
order to back drop this study against a background that reflects its emphasis on the dangerous 
outcomes, side effects, and end result of aspartame, we there should be a sufficient amount of 
literature that scientifically tackles this issue. However, highly discussed controversy looms over 
this subject due to political and medical reasons since its initial approval by the U.S. food and 
drug administration in 1974. 
Aspartame has been used as a sweetener in many products due to its low caloric value , and this  
discussing  and assessing its abundancy within  the population in from of  a used  beverages or 
delicacy sweetener will be through assessing the knowledge  and  awareness of  pharmacists  
about  its abundance within  a range of products, and though assessing this wide spread  
abundance , and awareness or lack of it within  the community pharmacists  society  we can 
determine the need to further  investigate  the  speculations  Stated  regarding it harmful effect 
since the lager the base of population using this product the larger the incandesces  that may  
appear  in future tense within  several year. A study tackling its safety was done at northeastern 
Ohio University College of medicine, this study managed only to recommend discouragement of 
this sweetener in-patient with history of mood disorders, regarding the awareness survey done 
amongst Community pharmacists mentioned that 49% of aspartame users might develop 
neurological problems. But to assess  the  awareness of community pharmacists regarding this 
matter we must first look at the population providing such data the demographic data illustrating  
  
 
the  population  of  community pharmacists  displayed  the majority of those  falling  under the 
scope of this study  to be  bachelor  Degree holder, juniors, due to the jobs available in Sudan for 
those graduating newly and recently finishing  their  internship  or housmanship, Are only 
community pharmacy jobs (77%), the  knowledge they show may be shadowed by speculation, 
where their lack of  experience  could be  subject  to personal  opinion  more than scientific data 
or actual cases. Master degree holders held a weak percentage of( 22%) also weakened  by the 
travel of  most master degree holders and a more( 1% )representing only 1 PHD holder 
encountered in this study their knowledge was furthermore  stressed  to the edges of speculation 
when questioned  if they knew the number of products containing aspartame , this also displayed 
that a large number( 51%)  were not  aware  of  the  aspartame products available in the market 
which may lead to them to go undetected when dispensing . and since very low are screen for the 
rare genetic conditions of phenylketonuria there is no possible way to know whether or not this 
aspartame user is harming himself or not. Regarding the number of products containing 
aspartame in Sudan and respectively the awareness of the community pharmacists whether these 
products actually contain aspartame or not, we will have to discuss the abunduacny of aspartame 
products worldwide, aspartame as stated by articles and studies of dr. lendensmith, is and can be 
found in over (6000) products often referred to as (sugar free or diet products).Exemplified in 
breath mints, cereals, sugar free gums, cacao mixes, coffee beverages, soft drinks and much 
more. community pharmacists in Sudan could only name  the obvious through mentioning 
alternative sweeteners , sussina ™ being the most mentioned with a percentage of (71.4%) and 
Ahermestas the least mentioned with a percentage of( 2.9%), these products are all products used 
instead of sugar to sweeten beverages and taking delicacies realizing non mentioned  only gums , 
candy sweets, drinks , or food rendering these overlooked and uncategorized  the knowledge of 
community pharmacists as aspartame containing products.  
Aspartame, being a very abundant sweetener and  low calorie  product is sometimes  considered  
an aid to help weight loss , given such knowledge it is highly suggested  and mentioned  though 
word  of  mouth  from patients to patient to aid in decreasing  sugar intake and to help with 
weight loss, this has rendered aspartame  as a highly dispensed product community pharmacists 
have reported that up to 10 patients are dispensed aspartame( 74.5%) of the time , and 3.6% of 
the time more than 30 patients per day. controversy still remains evident as the American 
diabetes association  actually recommends aspartame  to diabetic patients even though a diabetes 
specialist through a study has showed that aspartame actually precipitates clinical diabetes, 
causes poor diabetic control in patients using insulin’s or oral hypoglycemic and leads to the 
aggravation of diabetic complications such as retinopathy, cataracts, neuropathy and 
gastropathesis. Due  to the lack of  clinical studies on the harmful effects of aspartame  and the 
even shadowing controversy  Of  medical  and political controversy  that hindered the  
progression  of  such studies, community pharmacists and  medical  researchers have had to rely 
on their medical and scientific knowledge and the knowledge of pharmacological  metabolites to 
determine the possible harmful effect caused by excitatory  amino acids, phenylalanine, 
methanol  and DKP. Side effects mentioned by community pharmacists in this study were 
mainly GIT having  the  largest  percentage  of( 56.4%) ,( 53.6%) cancer, and 0.9% renal failure 
as the lower possible side effects , which were on par when received by the medical articles 
regarding aspartame side effects, which were mostly the same  ,  alongside other endocrine, eye 
and ear, skin  allergies , chest and neurological  side effects, giving  confirmation  that aspartame  
is and probably a much more hazardous chemical than reported .  
  
 
Aspartame , has also been linked to serious diseases  and disease  syndromes, but it is  also 
sometimes  misdiagnosed  because aspartame symptoms  are not as apparent  or  obvious  as  
said  and  usually next  other disease  which could be misleading. Community  pharmacists have 
mentioned some of these diseases whilst most of them actually knew or ever heard of aspartame 
to begin with , literature  has  mentioned  disease  such as psychological conditions , Alzheimer’s 
, Parkinson’s , ADHD, and others  as serious  syndrome  and disease to be   dealt with apart  
form  the number of community pharmacists that had no idea what is aspartame or its harmful 
cases were , a satisfying number of the study sample  mentioned  the  worsening  of  diabetes( 
30%) , Alzheimer’s( 28%) , ADHD (17.3%)  and psychological  disorders (15.8%) alongside 
other conditions as a result of aspartame poisoning or intoxication.  
Conclusion: 
Almost 68% from community pharmacists didn’t know the number of products that contain 
aspartame in their places they work.The majority of community pharmacists expect side effects 
can be developed due to aspartame regular use by patients but majority didn’t know what are the 
exact side effects and the exact diseases that can be worsened when using aspartame. 
In conclusion more studies should be conducted to fortify the general concept of the poisonous 
hazard of aspartame and fill the gaps of knowledge found within community, clinical and 
hospital pharmacists alongside other health professionals.  
Recommendations: 
Experimental researches must be done on aspartame side effects in man and animals to study 
safety profile. 
There must be a notification about aspartame side effects and diseases worsened by using 
aspartame to the all doctors, pharmacists and patients. 
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